Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX
AssigneeEpidauros Biotechnologie AG
InventorsLeszek Wojnowski, Klaus Gellner, Regina Eiselt
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpidauros Biotechnologie AG
InventorsLeszek Wojnowski, Klaus Gellner, Regina Eiselt
Estimating the term…
The present invention relates to polynucleotides encoding the CYP3AX protein and variants thereof. Further, the present invention also provides vectors comprising said polynucleotides, in particular vectors, wherein polynucleotides of the present invention are operatively linked to regulatory elements allowing expression in prokaryotic and/or eukaryotic host cells. In addition, the present invention relates to proteins encoded by said polynucleotides and antibodies specifically recognizing such proteins. The present invention also concerns transgenic non-human animals comprising the above-described polynucleotide or vectors. Moreover, the present invention relates to methods for identifying and obtaining drug candidates and inhibitors for therapy of disorders related to the malfunction of the CYP3AX genes as well as to methods of diagnosing the status of such disorders. The present invention also relates to methods for the identification of molecular variants of the CYP3AX polynucleotide or protein. The present invention furthermore provides pharmaceutical and diagnostic compositions comprising the above-described polynucleotides, vectors, proteins, antibodies, drugs and inhibitors obtainable by the above-described method. Said compositions are particularly useful for diagnosing and treating various diseases with drugs that are substrates, inhibitors or modulators of CYP3AX genes or their product.
An isolated polynucleotide encoding a cytochrome P450 (CYP) 3AX polypeptide that retains biological activity, selected from the group consisting of:
A CYP3AX-specific primer or probe consisting of an oligonucleotide that is about 15 to 50 nucleotides in length and that comprises a nucleotide sequence selected from the group consisting of a portion of SEQ ID NO:
Dependencies are inferred from the claim text.